These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23728171)

  • 41. Expression of complement components of the alternative pathway by glioma cell lines.
    Gasque P; Julen N; Ischenko AM; Picot C; Mauger C; Chauzy C; Ripoche J; Fontaine M
    J Immunol; 1992 Aug; 149(4):1381-7. PubMed ID: 1386864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes.
    Bhasym A; Gurjar BS; Prabhu S; Puraswani M; Khandelwal P; Saini H; Saini S; Chatterjee P; Bal V; George A; Coshic P; Patidar G; Hari P; Sinha A; Bagga A; Rath S; Guchhait P
    J Clin Immunol; 2019 Apr; 39(3):336-345. PubMed ID: 30945073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3.
    Sahu A; Pangburn MK
    Biochem Pharmacol; 1996 Mar; 51(6):797-804. PubMed ID: 8602875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C3b inactivator and beta 1H.
    Crossley LG
    Methods Enzymol; 1981; 80 Pt C():112-24. PubMed ID: 6210825
    [No Abstract]   [Full Text] [Related]  

  • 45. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
    PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
    Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
    Front Immunol; 2021; 12():615748. PubMed ID: 33732239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement C3: a molecular mosaic of binding sites.
    Fishelson Z
    Mol Immunol; 1991; 28(4-5):545-52. PubMed ID: 1829504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FHR5 Binds to Laminins, Uses Separate C3b and Surface-Binding Sites, and Activates Complement on Malondialdehyde-Acetaldehyde Surfaces.
    Rudnick RB; Chen Q; Stea ED; Hartmann A; Papac-Milicevic N; Person F; Wiesener M; Binder CJ; Wiech T; Skerka C; Zipfel PF
    J Immunol; 2018 Apr; 200(7):2280-2290. PubMed ID: 29483359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes.
    Cheung AK; Parker CJ; Wilcox L; Janatova J
    Kidney Int; 1989 Aug; 36(2):257-65. PubMed ID: 2528653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene.
    Xiao X; Ghossein C; Tortajada A; Zhang Y; Meyer N; Jones M; Borsa NG; Nester CM; Thomas CP; de Córdoba SR; Smith RJ
    Mol Immunol; 2016 Sep; 77():89-96. PubMed ID: 27490940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein.
    Urban A; Kowalska D; Stasiłojć G; Kuźniewska A; Skrobińska A; Arjona E; Alonso EC; Fenollosa Segarra MÁ; Jongerius I; Spaapen R; Satchell S; Thiel M; Ołdziej S; Rodriguez de Córdoba S; Okrój M
    Front Immunol; 2021; 12():724361. PubMed ID: 34899688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential modulation by glucocorticoids of alternative complement protein secretion in cells of the monocyte/macrophage lineage.
    Lemercier C; Julen N; Coulpier M; Dauchel H; Ozanne D; Fontaine M; Ripoche J
    Eur J Immunol; 1992 Apr; 22(4):909-15. PubMed ID: 1532362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adsorption of complement proteins on surfaces with a hydrophobicity gradient.
    Lin YS; Hlady V; Janatova J
    Biomaterials; 1992; 13(8):497-504. PubMed ID: 1321678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization.
    Kárpáti É; Papp A; Schneider AE; Hajnal D; Cserhalmi M; Csincsi ÁI; Uzonyi B; Józsi M
    Front Immunol; 2020; 11():1297. PubMed ID: 32765490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies.
    Irmscher S; Brix SR; Zipfel SLH; Halder LD; Mutlutürk S; Wulf S; Girdauskas E; Reichenspurner H; Stahl RAK; Jungnickel B; Wiech T; Zipfel PF; Skerka C
    Nat Commun; 2019 Jul; 10(1):2961. PubMed ID: 31273197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement.
    Misasi R; Huemer HP; Schwaeble W; Sölder E; Larcher C; Dierich MP
    Eur J Immunol; 1989 Sep; 19(9):1765-8. PubMed ID: 2529127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of membrane phospholipids on activation of the alternative complement pathway.
    Mold C
    J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of interferon-gamma on complement gene expression in different cell types.
    Lappin DF; Guc D; Hill A; McShane T; Whaley K
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.